Quality of Care: IBD Qorus™
Our two-part mission is to find a cure for Crohn’s disease and ulcerative colitis while doing everything we can to improve the daily quality of life for patients with inflammatory bowel disease (IBD).
That drive is what powers IBD Qorus, our groundbreaking collaboration between patients and healthcare providers to streamline and improve the quality of IBD care across the country to ensure all patients get similar high-level care, treatment, and improved outcomes.
In September 2020, the IBD Qorus collaborative embarked on a new improvement initiative called Treat to Target (TTT), a treatment strategy that aligns a remission-based therapeutic goal with the patient’s personal goals regarding quality of life. TTT is designed to encourage the physician to monitor the patient more frequently in order to assess progress towards these pre-determined goals and adjust treatment accordingly. While used in other chronic diseases, this would be the first time a TTT strategy has been explored in a real-world setting like IBD Qorus.
You can learn more about the Treat to Target initiative here.
This research program is made possible by support from: